Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.61 USD | +0.49% | +6.32% | -4.38% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.38% | 2.92B | |
+9.57% | 115B | |
+11.73% | 106B | |
-3.11% | 21.96B | |
-14.26% | 21.87B | |
-5.29% | 19.21B | |
-3.48% | 18.08B | |
-38.29% | 17.71B | |
+6.45% | 14.32B | |
+35.21% | 12.42B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Insider Sell: Denali Therapeutics